Instructions for Pulmicort (Budesonide) suspension for inhalation 20 sachets
English product name
pulmicort
Release form
susp. d/ingal. dosage one mg/two ml: single-dose containers 20 pcs.
susp. d/ingal dosed 500 ug/two ml: single-dose containers 20 pcs.
Description Pulmicort:
The inhalation suspension is white or almost white in colour and can be easily resuscitated.
1 ml
budesonide (micronized) 500μg
Auxiliary substances: sodium chloride, sodium citrate, dinatria edetate (sodium salt ethylenediaminetetraacetic acid (disubstituted)), polysorbate 80, citric acid (anhydrous), water purified.
two ml (1 dose) - containers single-dose polyethylene (5) - envelopes made of laminated foil (4) - packets of cardboard.
ATC codes
R03BA02 Budesonide
Clinical-pharmacological groups / Group affiliation
GCS for inhalations
Active substance
besonide
Pharmacotherapy group Pulmicort
Glucocorticosteroid for local use
Storage Conditions
The drug should be stored in a place inaccessible to children at temperatures below 30 ° C.
Best before date
The shelf life is two years. Do not apply after the expiry date indicated on the package.
After opening the envelope, the containers should be used for 3 months. Keep the containers in an envelope to protect them from light.
Open container must be used within 12 hours.
Testimony Pulmicort:
- Bronchial asthma requiring supportive GCS therapy;
- chronic obstructive pulmonary disease (COPD).
Method of use, course and dosage Pulmicort:
The dose of Pulmycourt® is set individually. If the recommended dose does not exceed 1 mg/day, the entire dose of the preparation is administered at one time. If you take a higher dose, it is recommended to divide it into 2 doses.
The initial dose for adults (including elderly patients) is one to two mg/day. The maintenance dose is 0.5-4 mg/day. In case of severe exacerbations, the dose can be increased.
For children aged six months and older, the recommended starting dose is 0.25-0.5 mg/day. If necessary, the dose can be increased to 1 mg/day. The maintenance dose is 0.25-2 mg/day.
Drug dose determination
Use in children
It is contraindicated in children under six months of age.
- Nosology (ICD codes)
- J44
- Other chronic obstructive pulmonary disease
- J45
- Astma
Pharmacological effect Pulmicort:
GCS for inhalation applications. Budesonide in the recommended doses has an anti-inflammatory effect in the bronchi, reducing the severity of symptoms and the incidence of bronchial asthma exacerbations with a lower incidence of side effects than when using systemic GCS.
Good product
